glp-1 drugs mechanism of action GLP1-GIP receptor co-agonists: a promising evolution in the treatment type 2 diabetes | Acta Diabetologica Glucagon-like peptide-1 receptor: mechanisms and

doi:10.1002/1099-0690(200301)2003:1 3.0.CO;2-I

Pissios, P

Viscovich, M., Lykkesfeldt, J., & Poulsen, H

Therapeutic strategies can therefore be envisioned to increase choroidal neuroprotective functions in perinatal conditions in which choroidal detoxifying systems may be sub-optimal, or when the brain is facing adverse oxidative and chemical stresses, such as exposure to pharmacological agents or environmental toxicants, hypoxia, and hyperbilirubinemia

Based on the analysis of relevant experimental and clinical studies, the main pathway of oxidative damage of pancreatic cells and endothelial dysfunction is also the main source of ROS increase and oxidative stress in diabetes (Darenskaya et al

Bariatric surgery patients